MockSutraCurrent Affairs

Novo Nordisk Launches Awiqli, World's First Once-Weekly Basal Insulin, in India

📅 10 July 2026National
Novo Nordisk Launches Awiqli, World's First Once-Weekly Basal Insulin, in India

Danish drugmaker Novo Nordisk launched Awiqli (insulin icodec) in India - the world's first once-weekly basal (long-acting) insulin approved for clinical use - for adults with Type 1 and Type 2 diabetes. It reduces injections from 365 to 52 per year. India is the seventh country to launch the drug (after the US, EU, Canada and others). A 70-unit weekly dose is priced at about Rs 261. India has over 101 million people living with diabetes and another 136 million with prediabetes. A single weekly injection replaces a full week of daily basal insulin doses.

Static GK

Novo Nordisk HQ: Bagsvaerd, Denmark | Insulin discovered by Banting & Best (1921) | World Diabetes Day: 14 November | Awiqli generic name: insulin icodec

More International Current Affairs